China's vaccine producer CanSino Biologics announced on Saturday that its recombinant Covid-19 vaccine has been issued a Good Manufacturing Practice (GMP) certificate by Hungarian authorities. Marking the second time a Chinese Covid-19 vaccine has received such a certificate from an EU country after Sinopharm.

Industry observers said the issuance of this certificate increased confidence in Chinese vaccines in European countries as blood clot fears linger among AstraZeneca and Johnson & Johnson vaccines. The acknowledgement has paved the way for more Chinese vaccines to get international recognition.